PE12.02 'It's almost as if stakeholder engagement is the annoying 'have-to-do…' recognizing 'tokenism' in stakeholder engagement - Perceptions of key role-players in HIV preventionE-posterEthics in HIV prevention research
PE13.01 What happened to my stock? Management and tracking of HIV self-testing (HIV-ST) kit distribution in rural KwaZulu-NatalE-posterHigh-throughput datasets in prevention science
PE14.01 Broadly neutralizing plasma antibodies effective against diverse autologous circulating viruses in infants with multivariant HIV-1 infectionE-posterHIV sequencing insights including viral diversity and antiretroviral resistance
PE14.02 HIV drug resistance assessment among seroconverters from the MTN-025/HOPE Open-Label Dapivirine Vaginal Ring StudyE-posterHIV sequencing insights including viral diversity and antiretroviral resistance
PE15.01 Transient Viral Exposures Drive Humoral Responses in HIV-1 Post-Treatment ControllersE-posterHIV sequencing insights including viral diversity and antiretroviral resistance
PE15.03 Analysis of IgG1 and IgG3 humoral response against the membrane proximal external region of HIV-1 envelope glycoproteinE-posterHumoral immunity
PE15.04 Association of HIV vaccine construct and VISP/R in 70 HIV vaccine trialsE-posterHumoral immunity
PE15.05LB Improved HIV+ infant survival is correlated with high levels of passively-acquired ADCC activity in two breastfeeding cohortsE-posterHumoral immunity
PE15.06LB Fusion peptide priming reduces immune responses to the HIV-1 envelope trimer base and leads to enhanced broadly neutralizing antibody responsesE-posterHumoral immunity
PE16.01 Barriers to prescribing pre-exposure prophylaxis by community-based sexually-transmitted-infection-friendly physicians in TaiwanE-posterImplementation science, including structural interventions, PrEP & VMMC
seek-warrow-warrow-eseek-e331 - 340 of 444 items